Data Composite

Drug Recalls

Recent drug recall reports from the FDA (US) and Health Canada, newest first. Each entry links to the full record -- product description, reason for recall, and severity classification -- refreshed daily.

Mallinckrodt Hospital Products Inc.

US Class II Ongoing · initiated 2026-08-06

Presence of particulate matter: glass and stopper piece

ACCORD HEALTHCARE, INC.

US Class II Ongoing · initiated 2026-08-06

Subpotent Drug

ACCORD HEALTHCARE, INC.

US Class II Ongoing · initiated 2026-08-06

Subpotent Drug

ACCORD HEALTHCARE, INC.

US Class II Ongoing · initiated 2026-08-06

Subpotent Drug

ACCORD HEALTHCARE, INC.

US Class II Ongoing · initiated 2026-08-06

Subpotent Drug

ACCORD HEALTHCARE, INC.

US Class II Ongoing · initiated 2026-08-06

Subpotent Drug

Baxter Healthcare Corporation

US Class II Ongoing · initiated 2026-08-06

CGMP Deviations

Baxter Healthcare Corporation

US Class II Ongoing · initiated 2026-08-06

CGMP Deviations

Baxter Healthcare Corporation

US Class II Ongoing · initiated 2026-08-06

CGMP Deviations

Baxter Healthcare Corporation

US Class II Ongoing · initiated 2026-08-06

CGMP Deviations

Baxter Healthcare Corporation

US Class II Ongoing · initiated 2026-08-06

CGMP Deviations

Baxter Healthcare Corporation

US Class II Ongoing · initiated 2026-08-06

CGMP Deviations

Baxter Healthcare Corporation

US Class II Ongoing · initiated 2026-08-06

CGMP Deviations

Baxter Healthcare Corporation

US Class II Ongoing · initiated 2026-08-06

CGMP Deviations

Baxter Healthcare Corporation

US Class II Ongoing · initiated 2026-08-06

CGMP Deviations

Baxter Healthcare Corporation

US Class II Ongoing · initiated 2026-08-06

CGMP Deviations

Baxter Healthcare Corporation

US Class II Ongoing · initiated 2026-08-06

CGMP Deviations

Baxter Healthcare Corporation

US Class II Ongoing · initiated 2026-08-06

CGMP Deviations

Baxter Healthcare Corporation

US Class II Ongoing · initiated 2026-08-06

CGMP Deviations

Baxter Healthcare Corporation

US Class II Ongoing · initiated 2026-08-06

CGMP Deviations

Baxter Healthcare Corporation

US Class II Ongoing · initiated 2026-08-06

CGMP Deviations

Baxter Healthcare Corporation

US Class II Ongoing · initiated 2026-08-06

CGMP Deviations

Baxter Healthcare Corporation

US Class II Ongoing · initiated 2026-08-06

CGMP Deviations

JAMP Methotrexate 10 mg Tablets

Canada Type II Ongoing · initiated 2026-08-05

Product quality. Verify whether your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product, or if you have any…

Zydus Pharmaceuticals (USA) Inc

US Class II Ongoing · initiated 2026-08-05

CGMP: Due to Out of Specification (OOS) result for N-Nitroso Mirabegron impurity.